The publisher, the industry analysis specialist, has released its latest report “Argentina Healthcare (Pharma and Medical Devices) Market Analysis, Regulatory, Reimbursement and Competitive Landscape”. The report is an essential source of information on analysis of the healthcare, regulatory and reimbursement landscape in Argentina. It identifies the key trends in the country's healthcare market and provides insights into its demographic, regulatory and reimbursement landscape, and healthcare infrastructure. Most importantly, the report provides valuable insights into the trends and segmentation of its pharmaceutical and medical device markets. It uses data and information sourced from proprietary databases, secondary research, and in-house analysis by the publisher's team of industry experts.
Argentina's pharmaceutical market ranks third in Latin America, after Brazil and Mexico, contributing approximately 11.2% to the Latin American market and 0.5% to the global market at laboratory exit prices. The pharmaceutical market of Argentina in terms of Argentine Pesos (ARS) was worth ARS114 billion in 2017, which increased at a CAGR of 51.9% to reach ARS399 billion in 2020. It is expected to rise even further, reaching 3.2 trillion by 2025. In terms of US dollars, the pharmaceutical market was worth $6.1 billion in 2017, which decreased at a negative CAGR of 8.1% to reach $4.7 billion in 2020. The market value is expected to decrease further, reaching $3.1 billion by 2025. Argentina's medical devices market has grown at a 3.1% CAGR from $4.9 billion in 2016 to $5.8 billion in 2021. It is expected to grow at a CAGR of 1.6% beginning in 2022 and reach $6 billion by 2027. The medical devices market in Argentina is 70-85% import-dependent. It was worth $555 million in 2021. China, the US, and Germany were the top exporters to Argentina in 2021. The Argentine Ministry of Health (MinSalud) approved the “Plan for the Development of Pharmaceutical Services Based on Primary Health Care” on November 10, 2021, through resolution 2949/2021, to support and grade the steps taken by pharmacy professionals for the health and quality of life needs of the population.
Argentina's pharmaceutical market ranks third in Latin America, after Brazil and Mexico, contributing approximately 11.2% to the Latin American market and 0.5% to the global market at laboratory exit prices. The pharmaceutical market of Argentina in terms of Argentine Pesos (ARS) was worth ARS114 billion in 2017, which increased at a CAGR of 51.9% to reach ARS399 billion in 2020. It is expected to rise even further, reaching 3.2 trillion by 2025. In terms of US dollars, the pharmaceutical market was worth $6.1 billion in 2017, which decreased at a negative CAGR of 8.1% to reach $4.7 billion in 2020. The market value is expected to decrease further, reaching $3.1 billion by 2025. Argentina's medical devices market has grown at a 3.1% CAGR from $4.9 billion in 2016 to $5.8 billion in 2021. It is expected to grow at a CAGR of 1.6% beginning in 2022 and reach $6 billion by 2027. The medical devices market in Argentina is 70-85% import-dependent. It was worth $555 million in 2021. China, the US, and Germany were the top exporters to Argentina in 2021. The Argentine Ministry of Health (MinSalud) approved the “Plan for the Development of Pharmaceutical Services Based on Primary Health Care” on November 10, 2021, through resolution 2949/2021, to support and grade the steps taken by pharmacy professionals for the health and quality of life needs of the population.
Scope
The report provides information on the healthcare, regulatory, and reimbursement landscape in Argentina, and includes:
- An overview of the pharmaceutical and medical device markets, comprising market size, segmentation, and key drivers and barriers.
- Profiles and SWOT analyses of the major players in the pharmaceutical market: Pfizer, Sanofi, Bayer, GlaxoSmithKline (GSK), and Roemmers.
- Profiles and SWOT analyses of the major players in the medical device market: Abbott, Fresenius, GE Healthcare, Terumo, and Coloplast.
- An insightful review of the COVID-19 epidemiology, COVID-19 impact and developments in healthcare market, HealthTech landscape, reimbursement and regulatory landscape, with analysis covering details of the country's healthcare reimbursement process, regulatory agencies and the approval processes for new drugs and medical devices.
- Detailed analysis of the country's healthcare policy highlights, demographics, healthcare infrastructure and healthcare expenditure.
- An overview of the opportunities for and challenges to growth in the Argentine healthcare market.
Reasons to Buy
This report will enhance your decision-making capability by allowing you to:
- Develop business strategies by understanding the trends shaping and driving the Indonesian healthcare market
- Drive revenues by understanding the key trends, reimbursement and regulatory policies, pharmaceutical market segments and companies likely to impact the Indonesian healthcare market in the future
- Formulate effective sales and marketing strategies by understanding the competitive landscape and analyzing competitors' performance
- Organize your sales and marketing efforts by identifying the market categories and segments that present the most opportunities for consolidation, investment and strategic partnership
Table of Contents
1. Table of Contents
2. Executive Summary
3. Overview of Pharmaceutical Market
4. Overview of Medical Devices Market
5. Pharmaceutical and Medical Devices Market - Drivers and Barriers
6. Deal Analysis
7. Healthtech Landscape
8. Market Access
9. Country Healthcare Landscape
13 Appendix
List of Tables
List of Figures
